Concepedia

Mirna Lechpammer

ML

Statistics

Publications

44

Citations

4.1K

H-Index

26

Active since

2002

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

University of California, Davis

Brigham and Women's Hospital

University of California Davis Medical Center

Mirna Lechpammer is an author at Harvard University specializing in medicine, oncology, and life sciences.

Publications per year

2002–2023

44

Publications

44

Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein

Keiichi Kondo, Jeff Klco, Eijiro Nakamura et al. · Cancer Cell · 2002 · 769 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +12

Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth

Keiichi Kondo, William Y. Kim, Mirna Lechpammer et al. · PLoS Biology · 2003 · 604 citations · Full text

Medicine, Cancer Biology, Oncology +17

Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal Cancer

Michael B. Atkins, Meredith M. Regan, David F. McDermott et al. · Clinical Cancer Research · 2005 · 401 citations · Full text

Medicine, Oncology, Pathology +16

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

Edgard Graner, Dan Tang, Sabrina Rossi et al. · Cancer Cell · 2004 · 365 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Microscopy with ultraviolet surface excitation for rapid slide-free histology

Farzad Fereidouni, Zachary T. Harmany, Miao Tian et al. · Nature Biomedical Engineering · 2017 · 270 citations · Full text

Medicine, Cell Biology, Pathology +11

1–5 of 44